SCHEMBL7258263

SCHEMBL7258263

O=S(=O)(O)Nc1ccc(N2CCN(Cc3ccc4ccccc4c3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
FAAH O00519 2/20 0.52
PKM P14618 1/20 0.51
DRD2 P14416 3/20 0.51
DRD4 P21917 3/20 0.51
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
MEN1 O00255 2/20 0.49
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
MC4R P32245 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7262997 0.81 ALDH1A1 (0.51) KMT2AFAAHMEN1ALDH1A1MAPT
SCHEMBL7258839 0.81 ALDH1A1 (0.62) FAAHDRD2DRD4ALDH1A1MAPT
SCHEMBL11817061 0.80 DRD4 (0.68) KMT2AFAAHPKMDRD2DRD4
SCHEMBL7258289 0.80 HTR2B (0.54) KMT2ADRD2DRD4MEN1ALDH1A1
SCHEMBL11830305 0.79 KMT2A (0.76) KMT2AFAAHPKMDRD2DRD4
SCHEMBL7258434 0.79 GFER (0.54) KMT2AFAAHDRD2DRD4HDAC1
SCHEMBL7262647 0.77 LMNA (0.56) KMT2AMEN1ALDH1A1MAPTNPC1
SCHEMBL11819664 0.75 DRD4 (0.65) KMT2ADRD2DRD4MEN1ALDH1A1
SCHEMBL11821778 0.75 KMT2A (0.64) KMT2APKMDRD2DRD4ALDH1A1
SCHEMBL7258467 0.75 KMT2A (0.50) KMT2AMEN1ALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003082263-A1 SULFAMIC ACIDS AS INHIBITORS OF HUMAN CYTOPLASMIC PROTEIN TYROSINE PHOSPHATASES ONTOGEN CORPORATION (US) 2003-10-09 WO disclosed